Business Wire

CAI Marks Thirty Years Advancing Operational Readiness and Excellence Across Life Sciences and Mission-Critical Industries

13.4.2026 14:57:00 EEST | Business Wire | Press release

Share

Marking 30 years as an industry leader, CAI, a professional services firm composed of engineering, quality and operations experts, is defining what operational readiness means for highly regulated life sciences and mission-critical industries. As the field enters a new era of digital transformation and innovation, the deep technical knowledge, structured methodologies, risk-based frameworks and teams of experts at CAI help clients bridge emerging technologies with practical execution.

“At CAI, our legacy is not simply about longevity,” said CAI CEO Sheena Dempsey. “Our engineers and quality and operations experts consistently deliver solutions that allow clients to operate confidently and effectively. As we move forward into a new decade, we are committed to continuing to evolve and innovate readiness and best practices, whether at a single facility or for global organizations that need to scale across complex manufacturing networks.”

For more than 30 years, CAI has helped define what operational readiness means in highly regulated environments. At a time when few firms specialized in CQV (commissioning, qualification, and validation), CAI established itself as an early leader in this rapidly evolving industry and built on that foundation over time. The results for its clients include:

  • Accelerated facility and system readiness to support quicker delivery of medicines and therapies to patients.
  • Rigorous CQV to ensure systems meet global compliance standards and stand up to regulatory scrutiny.
  • Reduced risk and project delays by identifying and resolving issues early, helping organizations avoid costly rework and keep complex projects on track.
  • Scalable operational excellence to enable global organizations to standardize best practices and maintain reliable, compliant operations across complex manufacturing networks.

CAI delivers operational readiness and performance excellence across both Life Sciences and Mission-Critical environments, helping organizations navigate complexity with confidence.

Life Sciences

  • Advance operational readiness by delivering integrated commissioning, qualification, and validation (CQV) that ensures facilities, systems, and processes are inspection-ready from day one
  • Strengthen operational excellence by optimizing manufacturing and quality systems to improve performance, consistency, and long-term compliance
  • Implement structured, risk-based frameworks that enable efficient startup, sustained control, and proactive regulatory readiness
  • Guide organizations through critical readiness milestones by aligning people, processes, and technology to accelerate time to market and reliable operations

Mission Critical

  • Lead commissioning management, scheduling, and staffing for complex data center developments
  • Perform design reviews and integrated systems testing to ensure reliability and performance
  • Support digital integration and operational excellence across facilities and systems
  • Develop maintenance strategies to sustain uptime and long-term efficiency

“At the heart of our sustained success is our amazing team of experts that continuously support operational readiness and excellence,” Dempsey added. “Through a shared commitment to doing the work right, our employees are empowered to develop solutions, share lessons learned, and continuously raise the bar. That collective expertise is how we deliver consistent results across projects of varying sizes and complexities across the globe.”

CAI Founder Bob Chew said, “Looking back on the past three decades, I’m incredibly proud of how far our company has come and the role our people have played in supporting the safe, efficient delivery of medicines and critical therapies to patients worldwide. Our growth has always been driven by listening to our clients and anticipating what they’ll need next. As we enter our fourth decade, that commitment is unwavering and guides us to help shape the future of life sciences and mission-critical operations.”

ABOUT CAI

CAI is a professional services firm composed of engineering, quality, and operations experts dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments. With deep roots in CQV (commissioning, qualification, validation), CAI has evolved over the past 30 years alongside the industries it serves, helping organizations bring complex facilities, systems, and technologies online with confidence.

The elite team at CAI combines deep technical expertise with proven processes and modern tools to deliver projects on time and within budget, supporting outcomes that matter in highly regulated environments. Over three decades, CAI has embraced new modalities and guided clients through digital transformation while strengthening operational readiness. As industry demands grow, CAI continues to define the next era of agility, resilience, and operational excellence.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260413035076/en/

Contacts

Blair Ciecko, bciecko@cglife.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Elliptic Secures $120 Million Investment From Nasdaq Ventures, Deutsche Bank, One Peak and the British Business Bank12.5.2026 17:05:00 EEST | Press release

Elliptic, the global leader in digital asset decisioning, today announced the closing of a $120 million Series D fundraise led by One Peak, with participation from Nasdaq Ventures, Deutsche Bank and the British Business Bank. The round values Elliptic at $670 million. These investors are among the most consequential institutions in global finance, together responsible for trillions in daily market activity, and they have placed their confidence in Elliptic. It is a signal about where the financial system is heading and who is trusted to underpin it, with Elliptic screening more of the global on-chain economy than any other private sector provider. The fundraise will accelerate Elliptic's mission to deliver the enterprise-grade on-chain analytics for the world's largest and most demanding banks, fintechs, government agencies and crypto and payments companies in the world. “As digital assets become more embedded in the global financial system, institutions need trusted infrastructure to

Rigaku Accelerates Next-generation Semiconductor Metrology Development Leveraging World-Class Research Infrastructure12.5.2026 17:00:00 EEST | Press release

Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced the expansion of its development of metrology technologies for next-generation semiconductors, leveraging global research environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512888328/en/ Signing ceremony with imec held on April 9 As part of this initiative, Rigaku is working with imec, a world-leading semiconductor research and innovation hub headquartered in Belgium, under a three-year development program. Through this effort, Rigaku will advance its core X-ray technologies, including 3D device metrology, high-sensitivity detection of ultrathin films and trace elements, and non-destructive inspection of microscopic defects. As semiconductor devices evolve toward advanced architectures such as Gate-All-Around (GAA) and

Aster Guardians Global Nursing Award Announces Top 10 Finalists for 202612.5.2026 16:54:00 EEST | Press release

On the occasion of International Nurses Day, Aster DM Healthcare has announced the Top 10 finalists for the fifth edition of the Aster Guardians Global Nursing Award 2026, selected from over 134,000 registrations across 214* countries and economies. One of the Top 10 finalists will be honoured with the grand title and a prize of USD 250,000. Aster has appointed Ernst & Young LLP as the 'Process Advisors' of the award. EY has defined a three-stage evaluation process to determine the finalists and the winner. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512872373/en/ Aster Guardians Global Nursing Awards 2026 - Top 10 Finalists (Photo: AETOSWire) The top 10 finalists for 2026 includes: Dr. Agimol Pradeep (United Kingdom), Dr. Aidah Alkaissi (Sweden), Dinah Sevilla (The Kingdom of Saudi Arabia), Dr. Hammoda Abu-Odah (Hong Kong SAR, China), Hindumbi Kaurom Kakkada (India), Johana Patricia Galvan Barrios (Colombia), Josephin

Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress12.5.2026 16:30:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that data from key programs in its Hematology and Oncology franchises will be presented at the European Hematology Association (EHA) 2026 Congress, to be held June 11 - 14, 2026, in Stockholm, Sweden. “The breadth of the data that will be showcased at the 2026 EHA Congress highlights the continued advancement of our Hematology and Oncology pipeline and our focus on delivering differentiated medicines for patients with cancer and hematologic diseases,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “These presentations include findings from the frontMIND study, which support the U.S. and EU regulatory applications for tafasitamab (Monjuvi®/Minjuvi®) in patients with first-line diffuse large B-cell lymphoma (DLBCL). Additionally, data presentations for INCA033989, which support our Phase 3 trials, demonstrate the steady advancement of this molecularly targeted therapy that has the potential to revolutionize

Lenovo Enables One-Week Deployment of Production-Ready Agentic AI to Transform Enterprise Workflows12.5.2026 16:00:00 EEST | Press release

Lenovo is enabling enterprises to deploy production-ready, agentic AI solutions in as little as one week1, eliminating the long development cycles that typically delay AI from reaching production, while maintaining enterprise-grade security, governance, and control. This is not theoretical, independent analysis from Signal65 confirms these results in real-world deployments. Lenovo’s Knowledge Super Agent reduced time spent on knowledge-related tasks by 30%, saving up to 120 hours per employee annually. In multiple deployments, organizations reached production up to 24× faster than with custom-built approaches, demonstrating how faster, secure deployment translates directly into faster business outcomes. These results reflect faster deployment and more efficient AI utilization, where each interaction delivers measurable business value. Delivered through the Lenovo AI Library as part of Lenovo Hybrid AI Advantage™, this approach allows organizations to move directly from pilot to operati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye